Hiroshi Nakamura

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Bipolar Disorder

Top Venues

Journal of child and adolescent psychopharmacology

Annals of general psychiatry

Neuropsychopharmacology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Takuya Saito, Saori Sugimoto, Reiko Sakaguchi, Hiroshi Nakamura, Jun Ishigooka
Efficacy and Safety of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study. Journal of child and adolescent psychopharmacology 32 (1) (2022)
Takuya Saito, Yohei Hyodo, Reiko Sakaguchi, Hiroshi Nakamura, Jun Ishigooka
Long-Term Safety and Efficacy of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 52-Week, Multicenter, Open-Label Extension Study. Journal of child and adolescent psychopharmacology (2021)
Mitsukuni Murasaki, Yoshifumi Inoue, Hiroshi Nakamura, Toshihiko Kinoshita
Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies. Annals of general psychiatry 20 (1) (2021)
Masashi Ikeda, Jun Ishigooka, Ichiro Naoi, Masahiro Matsumoto, Yuichi Kanamori, Hiroshi Nakamura, Teruhiko Higuchi
Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study. CNS drugs 34 (1) (2021)
Philip D Harvey, Hiroshi Nakamura, Sadanori Miura
Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study. Neuropsychopharmacology reports 40 (1) (2019)